Sökning: onr:"swepub:oai:DiVA.org:uu-531098" >
Impact of the COVID...
-
Ekberg, SaraKarolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.
(författare)
Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study
- Artikel/kapitelEngelska2024
Förlag, utgivningsår, omfång ...
-
Medical Journals Sweden,2024
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-531098
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-531098URI
-
https://doi.org/10.2340/1651-226X.2024.35238DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:238591352URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:158330555URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background & purpose: The COVID-19 pandemic posed a large challenge for healthcare systems across the world. Comprehensive data on the impact of the COVID-19 pandemic on incidence and mortality in lymphoma are lacking.Patients/methods: Using data from the Swedish lymphoma register, we compare incidence and 1-year survival of lymphoma patients in Sweden before (2017-2019) and during the pandemic (2020 and 2021).Results: Fewer patients were diagnosed with lymphomas during March-June 2020, but the annual incidence rates for 2020 and 2021 were similar to those of 2017-2019. A larger proportion of patients presented with stage IV disease during 2021. There were no differences in other base-line characteristics nor application of active treatment in pre-pandemic and pandemic years. One-year overall survival was not inferior among lymphoma patients during the pandemic years compared to pre-pandemic years i.e., 2017-2019.Interpretation: The COVID-19 pandemic had limited impact on the incidence and mortality of lymphoma in Sweden.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Molin, Daniel,1969-Uppsala universitet,Cancerimmunterapi(Swepub:uu)danimoli
(författare)
-
Pahnke, SimonUppsala universitet,Cancerprecisionsmedicin(Swepub:uu)simpa740
(författare)
-
Bergstroem, FannyKarolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.
(författare)
-
Branvall, ElsaKarolinska Institutet
(författare)
-
Smedby, Karin E.Karolinska Institutet,Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.;Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.
(författare)
-
Waesterlid, ToveKarolinska Institutet,Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.;Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Dept Med Solna, SE-17176 Stockholm, Sweden.
(författare)
-
Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.Cancerimmunterapi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Acta Oncologica: Medical Journals Sweden63, s. 164-1680284-186X1651-226X
Internetlänk
Hitta via bibliotek
Till lärosätets databas